Malignant lymphoma in the HIV‐positive patient

A Meister, M Hentrich, C Wyen… - European journal of …, 2018 - Wiley Online Library
The introduction of combination antiretroviral therapy (cART) drastically improved
performance status, immune function, and life expectancy of HIV‐infected individuals. In …

Ageing with HIV

P McGettrick, E Alvarez Barco, PWG Mallon - Healthcare, 2018 - mdpi.com
The population of people living with HIV (PLWH) is growing older with an estimated 4 million
over the age of 50 years, a figure which has doubled since the introduction of effective …

Incidence of first and second primary cancers diagnosed among people with HIV, 1985–2013: a population-based, registry linkage study

NA Hessol, H Whittemore, E Vittinghoff, LC Hsu… - The lancet HIV, 2018 - thelancet.com
Background Cancer survivors are at increased risk for subsequent primary cancers. People
living with HIV are at increased risk for AIDS-defining and non-AIDS-defining cancers, but …

Non-AIDS defining cancer (NADC) among HIV-infected patients at an oncology tertiary-care center in Mexico

P Cornejo-Juárez, D Cavildo-Jerónimo… - AIDS Research and …, 2018 - Springer
Background Non-AIDS defining cancers (NADCs) have been an increasing cause of
morbidity and mortality in patients with HIV. There is no data on the spectrum of NADCs in …

Survival after cancer diagnosis in a cohort of HIV-positive individuals in Latin America

VI Fink, CA Jenkins, JL Castilho, AK Person… - Infectious agents and …, 2018 - Springer
Background This study aimed to evaluate trends and predictors of survival after cancer
diagnosis in persons living with HIV in the Caribbean, Central, and South America network …

[PDF][PDF] Prostate cancer in HIV-positive patients: A review of the literature

A Facciolà, M Ceccarelli, EV Rullo, F d'Aleo… - AIDS …, 2018 - researchgate.net
Objective: Highly Active Antiretroviral Therapy (HAART) has significantly increased the
survival of people living with HIV/AIDS (PLWHA) and reduced the incidence of AIDS-related …

Change in pattern of secondary cancers after Kaposi sarcoma in the era of antiretroviral therapy

F Mukhtar, M Ilozumba, O Utuama, O Cimenler - JAMA oncology, 2018 - jamanetwork.com
Importance Studies performed in the 1980s and early 1990s have shown that people who
develop Kaposi sarcoma (KS) are at higher risk of developing other cancers. The …

Blood Epstein–Barr virus DNA does not predict outcome in advanced HIV-associated Hodgkin lymphoma

I Ul-Haq, A Dalla Pria, E Suardi, DJ Pinato, F Froeling… - Medical oncology, 2018 - Springer
In HIV-seronegative patients with advanced Hodgkin lymphoma (HL), Epstein–Barr virus
(EBV) viraemia at diagnosis predicts a worse progression-free survival (PFS), independent …

Prevalence of HIV in patients with malignancy and of malignancy in HIV patients in a tertiary care center from North India

S Sinha, A Agarwal, K Gupta, D Mandal… - Current HIV …, 2018 - ingentaconnect.com
Background and Objectives: People living with HIV/AIDS are at an increased risk of
developing cancer. The goals of this study were to obtain data on the prevalence of HIV in …

Dysregulation of autophagy in rat liver with mitochondrial DNA depletion induced by the nucleoside analogue zidovudine

A Santos-Llamas, MJ Monte, JJG Marin, MJ Perez - Archives of Toxicology, 2018 - Springer
The nucleoside reverse transcriptase inhibitor zidovudine (AZT), used in HIV infection
treatment, induces mitochondrial DNA (mtDNA) depletion. A cause–effect relationship …